Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Laquinimod - New Promising Treatment for Multiple Sclerosis
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
First NW patient to receive OHSU/VAMC-invented MS drug
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.

Pages